FDA Approves Sarepta’s Gene Therapy for Duchenne Muscular Dystrophy

In a decision the gene therapy space and Duchenne muscular dystrophy community has been eagerly anticipating, the FDA on Thursday approved Elevidys (delandistrogene moxeparvovec-rokl) as the first-ever gene therapy for DMD.